4-(Trifluoromethyl)benzoic acid-¹³C₆

Art. -Nr.: HY-W015198S Reinheit: 98.31%: Data Sheet
COA

SDS
Handling Instructions
FAQs
Technical Support

4-(Trifluoromethyl)benzoic acid-¹³C₆ is the ¹³C labeled 4-(Trifluoromethyl)benzoic acid.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

4-(Trifluoromethyl)benzoic acid-<sup>13</sup>C<sub>6</sub>

4-(Trifluoromethyl)benzoic acid-¹³C₆ Chemische Struktur

CAS. Nr. : 2731552-41-1

Größe	Verfügbarkeit	Menge
1 mg	Auf Lager	Estimated Time of Arrival: December 31
5 mg	Auf Lager	Estimated Time of Arrival: December 31
10 mg	Auf Lager	Estimated Time of Arrival: December 31
25 mg	Angebot einholen	Estimated Time of Arrival: December 31
50 mg	Angebot einholen
100 mg	Angebot einholen

or Massenanfrage

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

This product is a controlled substance and not for sale in your territory.

Other Forms of 4-(Trifluoromethyl)benzoic acid-¹³C₆:

4-(Trifluoromethyl)benzoic acid In-stock

Spezialitätsempfehlungen

•Related Small Molecules:

•Related Proteins:

Biologische Aktivität
Reinheit & Dokumentation
Verweise
Kundenbewertung

Beschreibung

4-(Trifluoromethyl)benzoic acid-¹³C₆ is the ¹³C labeled 4-(Trifluoromethyl)benzoic acid^[1].

Application

1. This compound can be used as a tracer.
2. This compound can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.

In Vitro

Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Molekulargewicht

196.08

Formel

C₂¹³C₆H₅F₃O₂

CAS. Nr.

2731552-41-1

Unlabeled CAS

455-24-3

Appearance

Solid

Color

White to off-white

SMILES

OC([13C]1=[13CH][13CH]=[13C](C(F)(F)F)[13CH]=[13CH]1)=O

Versand

Room temperature in continental US; may vary elsewhere.

Speicherung

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Reinheit & Dokumentation

Purity: 98.31%

Select Batch:

Data Sheet (266 KB) SDS (252 KB)

COA (247 KB) HNMR (152 KB) RP-HPLC (110 KB) MS (110 KB)

Handling Instructions (2659 KB)

Verweise

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief]